Fondazione Epatocentro Ticino, 2020: Swiss phase 2 randomised placebo-controlled single-blind trial of methylene blue in 29 SARS-CoV-2 patients, completed, no results posted.
Despite enormous progress in understanding COVID-19, there is little evidence that a solution, therapeutic or preventive, is close to being achieved.
Registry record field
Fondazione Epatocentro Ticino, 2020: Swiss phase 2 randomised placebo-controlled single-blind trial of methylene blue in 29 SARS-CoV-2 patients, completed, no results posted. Study type: other.
